Evidence map›Paper›PMID 24227780›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

BANK1 controls CpG-induced IL-6 secretion via a p38 and MNK1/2/eIF4E translation initiation pathway.

Ying-Yu Wu, Ramesh Kumar, Mohammed Shamsul Haque, Casimiro Castillejo-López, Marta E Alarcón-Riquelme

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Frontiers in immunology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. TheScience signaling · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Trans-Ethnic Mapping ofInternational journal of molecular sciences · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ying-Yu WuArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Ramesh Kumar
Mohammed Shamsul Haque
Casimiro Castillejo-López
Marta E Alarcón-Riquelme
Oklahoma Medical Research Foundation · USPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ES

Funding

VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KAUFMAN, KENNETH M · 2004 to 2011
$21.0M
Molecular Mechanisms and Genetics of AutoimmunityP20GM103456 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2012 to 2013
$4.8M
NCRR NIH HHS P20 RR020143NIGMS NIH HHS GM103456NIGMS NIH HHS P20 GM103456
6 · The paper itself

Abstract

BANK1, an adaptor protein expressed in B cells, plays a little understood role in B cell signaling. Because BANK1 contains an N-terminal putative Toll/IL-1R receptor domain, we used mouse Bank1(-/-) splenic B cells to test whether BANK1 affects signaling induced by the TLR9 agonist CpG. Following CpG stimulation, BANK1 deficiency reduced p38 phosphorylation without affecting that of ERK or JNK and reduced IL-6 secretion. Bank1(-/-) B cells showed reduced phosphorylation of MNK1/2 and eIF4E, suggesting an effect on translation initiation, whereas Bank1(-/-) had no effect on IL-6 mRNA stability, thus suggesting that BANK1 has no effect on MK2 signaling. IL-6 secretion observed when CpG stimulation was combined with anti-CD40 was reduced in the absence of BANK1. Whereas in the presence of anti-CD40 stimulation CpG induced a stronger phosphorylation of AKT, mTOR, and 4E-BP1, Bank1(-/-) had no effect on phosphorylation of mTOR and 4E-BP1, and a weak effect on AKT, implying that BANK1 does not affect the release of eIF4E by phospho-4E-BP1. Taken together, these data establish a previously unrecognized role for BANK1 in CpG-induced responses by splenic B cells on p38 signaling and control of translation initiation of IL-6 via MNK1/2 and eIF4E.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAutoimmunityB-LymphocytesCarrier ProteinsCell Cycle ProteinsCpG IslandsEnzyme ActivationEukaryotic Initiation Factor-4EEukaryotic Initiation FactorsInterleukin-6Intracellular Signaling Peptides and ProteinsMAP-Kinase-Activated Kinase 2MAP Kinase Signaling SystemMiceMice, Inbred C57BLAdaptor Proteins, Signal TransducingAkt1 protein, mouseBANK1 protein, mouseCarrier ProteinsCell Cycle ProteinsEif4ebp1 protein, mouseEukaryotic Initiation Factor-4EEukaryotic Initiation FactorsInterleukin-6interleukin-6, mouseIntracellular Signaling Peptides and ProteinsMAP-Kinase-Activated Kinase 2Mknk1 protein, mouseMknk2 protein, mousemTOR protein, mousep38 Mitogen-Activated Protein KinasesPhosphoproteinsProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktRNA, MessengerTOR Serine-Threonine Kinases

Identifiers

PMID24227780
PMCPMC3858538
OpenAlexW2132730798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.